Biocon’s late-stage clinical trial of its experimental oral insulin drug to treat type-II diabetes has not met the desired results. However, the company would continue with the development and initiate discussions for partnership with global pharmaceutical companies.

Biocon’s study drug IN-105 was in the final phase of clinical trials. Oral insulin is a novel drug research initiative of Biocon which aims to cure type-II diabetes in patients. If Biocon’s oral drug trials become successful it would be the first of its kind.

IN105 is a tablet using a proprietary polymer technology acquired by Biocon from US firm Nobex Corp. Nobex — whose IP assets were later bought by Biocon when it filed for bankruptcy in 2005. Nobex had developed a technology that allows modifications to the insulin structure to make it suitable for oral delivery.


News Archives:
SelectHeadline Top Story: RIL gas output from KG-D6 to touch 60 mscmd by April [12 Jan 2011] Biocon trials for oral insulin drug fail to meet target [12 Jan 2011] Tata Steel sales dip 4.8% in Q3 [12 Jan 2011] Rural demand revives cement sales in Dec [12 Jan 2011] Aurobindo to divest stake in loss-making Chinese venture [12 Jan 2011] Allahabad Bank to raise Rs 2,600 cr thru Tier II bonds [12 Jan 2011] Vivimed Labs closes in on $50-m European buy [12 Jan 2011] Rel Broadcast to buy Imagine Showbiz [12 Jan 2011] Apollo Tyres scales up investment plan [12 Jan 2011] L&T Power expects sales of $3 b by 2015 [12 Jan 2011] Macquarie Fund to invest 580 cr in Moser Baer’s power plant [12 Jan 2011] Banks may get to spread 10K crore pension liability over many years [12 Jan 2011] Post-split, Hero group to bring in 3-wheelers [11 Jan 2011] Cash-strapped Haldia Petro seeks more time to repay 2,500-cr loans [11 Jan 2011] IVRCL Infra looks to exit Hindustan Dorr [11 Jan 2011] ITC-Welcomgroup to invest $2 b to double room inventory [11 Jan 2011] Bajaj Electricals diversifies product portfolio [11 Jan 2011] Suryavanshi Spinning in Rs 120-crore expansion mode [11 Jan 2011] R-Power, NTPC sign solar energy deal [11 Jan 2011] RIL against new gas pipeline in Andhra [11 Jan 2011] Duty-free sugar imports extended till March 31 [11 Jan 2011] Rubber imports double to Rs 2,000 cr in April-Oct [11 Jan 2011] Auto sector demand pushes up steel output in Dec [11 Jan 2011] Greaves Cotton to supply diesel engines to Tata Motors [11 Jan 2011] Dec exports up 36.4%, highest in 33 months [10 Jan 2011] Sugarcane fair price likely to be hiked by Rs. 4 to Rs. 143 a quintal [10 Jan 2011] L&T eyes Rs 5,000 crore monorail project in Gujarat [10 Jan 2011] PowerGrid plans Rs 10,000-cr bond issue in 2011-12 [10 Jan 2011] Essar Shipping to invest $1 billion in fleet expansion [10 Jan 2011] Anti-dumping duty on tyre manufacturers quashed [10 Jan 2011] Jindal subsidiaries get coal blocks in Mozambique for exploration [10 Jan 2011] Reliance Retail to open 150 stores by March-end [10 Jan 2011] Fortis Healthcare plans standalone dialysis, diagnostic centres and eyes expansion in West, S-E Asia [10 Jan 2011] JK Paper eyes new high growth segments [10 Jan 2011] ITC arm to add more stores [10 Jan 2011] Food inflation soars to 18.32% [7 Jan 2011] Direct tax kitty up 19 pc at Rs 2.99 lakh cr in Apr-Dec'10 [7 Jan 2011] JSW to step up coking coal imports by 40% next fiscal [7 Jan 2011] India to grow 8.8%, but inflation a concern: IMF [7 Jan 2011] MRPL plans spot buys as Iran row continues [7 Jan 2011] Suzlon bags 865-cr order [7 Jan 2011] Eicher plans to set up branded sales, service outlets [7 Jan 2011] SBI to set up 600 financial inclusion centres [7 Jan 2011] Unitech promoters infuse Rs 380 crore to increase stake [7 Jan 2011] Promoters to increase stake in R-Infra to 48% [7 Jan 2011] SAIL scouts for tech provider for CRGO steel [7 Jan 2011] Lupin lines up $50 million for acquisitions in Latin America [6 Jan 2011] RIL abandons exploratory well in K-G basin [6 Jan 2011] Diesel rate hike put off to check prices [6 Jan 2011] Jindal Poly may seek PE investment for subsidiary [6 Jan 2011] Indian Bank to enter life insurance, restart MF biz [6 Jan 2011] Apollo to set up 12 new hospitals [6 Jan 2011] IT majors tipped to post 4% profit jump in Dec quarter [6 Jan 2011] Merck, Ranbaxy call off research pact [6 Jan 2011] SBI may raise Rs 1k cr via retail bonds [6 Jan 2011] BOC India to delist; fixes buyback price at Rs 225.2 [6 Jan 2011] Ultratech Cement to set up Rs 2,000-Cr cement unit in Jhunjhunu [6 Jan 2011] BHEL plans NBFC to fund power projects [6 Jan 2011] BPCL sees petrochem, gas as new growth areas [5 Jan 2011] Maruti sales jump 17% in Dec while Ashok Leyland reports 69% rise in first 9 months [5 Jan 2011] NMDC, MMTC lock horns over iron ore supply to Japanese firms [5 Jan 2011] RPower targets 1,000 MW renewable capacity [5 Jan 2011] Dena Bank sees 29% jump in business at Rs. 1 lakh cr, UBI's global biz crosses Rs 3,20,000 cr [5 Jan 2011] Jindal SAW signs pact with Rajasthan for iron ore mining [5 Jan 2011] Essar bets big on ports business [5 Jan 2011] GEECL to invest in coal bed methane block in TN [5 Jan 2011] Fertiliser cos could get Rs 2,700 cr in three years to improve efficiency [5 Jan 2011]

Currently, investors should hold minimum 25% of entire equity assets in cash form until end of January. The outlook remains strong in the medium-to-long term. However, they may go through rough patches until end of March because of several reasons.

: The flow of FDI money has dipped for first time in last six years on a year-on-year basis by 25%. The current account deficit is now largely financed by FII fund flows rather than FDI money, which is a major cause of concern.

: Inflation too can spoil the perception of foreign institutional investors (FIIs) for another one month, but the base effect which will start playing out from March will help mitigate the risk arising from inflation.

Banking sector is under stress. There is a gross mismatch between the lending and deposit rates which will affect the December 2010 quarter results. Deposit rates surged by 200 bps, where as lending rates inched up by 50-75 bps since the month of December. Also, banks may not make much money out of the treasury source because the yields are holding steady.

GudMrng CB. Any outlook for Cairn? Can I go long with 5800 CE? or any other trade with nifty option?

CB, Kartik,
will Ongc go above 1195 today..please guide sir

CB/karthik,
can l sell my existing stocks.

Investors should look at companies that are catering to agricultural sector like pesticide manufacturers, agricultural input manufacturers, as they would be the beneficiaries of rising food prices.

Media companies are a good bet as they remain unaffected by rise in interest costs. However, investors should be selective.

There are many large-cap companies that are least leveraged with absolutely no debt on the books like Hindustan Zinc. It is a zero debt company with huge cash. Hence, rising commodity prices will be a positive for this stock.